Essential role of Toll-like receptor 2 in macrophage activation by glycogen

Glycobiology

Volumn 22, Issue 1, 2012, Pages 146-159

  Kakutani, Ryo ^a   Adachi, Yoshiyuki ^b   Takata, Hiroki ^a   Kuriki, Takashi ^a   Ohno, Naohito ^b  

^a EZAKI GLICO CO LTD   (Japan)

^b TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

carbohydrate; glycogen; immunostimulating activity; macrophage; Toll like receptor 2

Indexed keywords

BETA GLUCAN; CD11B ANTIGEN; CD14 ANTIGEN; DECTIN 1; GLUCAN 1,4 ALPHA GLUCOSIDASE; GLYCOGEN; I KAPPA B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE; PROTEIN MD 2; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GLYCOGEN ANALYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LYMPHOCYTE; MACROPHAGE ACTIVATION; MOUSE; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL;

ANIMALS; CYTOKINES; GENE KNOCKOUT TECHNIQUES; GENES, REPORTER; GLYCOGEN; HEK293 CELLS; HUMANS; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; LUCIFERASES, RENILLA; MACROPHAGE ACTIVATION; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NF-KAPPA B; NITRIC OXIDE; PHOSPHORYLATION; PROTEIN BINDING; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 83255189443     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwr122     Document Type: Article

References (48)

1. Adachi Y, Ishii T, Ikeda Y, Hoshino A, Tamura H, Aketagawa J, Tanaka S, Ohno N. 2004. Characterization of β-glucan recognition Site on C-type lectin, dectin 1. Infect Immun. 72:4159-4171. (Pubitemid 38821931)
2. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, Radolf JD, Klimpel GR, Godowski P, Zychlinsky A. 1999. Cell activation and apopto-sis by bacterial lipoproteins through Toll-like receptor-2. Science. 285:736-739.
3. Baba O. 1993. Production of monoclonal antibody that recognizes glycogen and its application for immunohistochemistry. Kokubyo Gakkai Zasshi. 60:264-287.
4. Bausinger H, Lipsker D, Ziylan U, Manie S, Briand JP, Cazenave JP, Muller S, Haeuw JF, Davanat C, de la Salle H, et al. 2002. Endotoxin-free heat shock protein 70 fails to induce APC activation. Eur J Immunol. 32:3708-3713. (Pubitemid 36032655)
5. Beg AA. 2002. Endogenous ligands of Toll-like receptors: Implications for regulating inflammatory and immune responses. Trends Immunol. 23:509-512. (Pubitemid 35223541)
6. Bittencourt VC, Figueiredo RT, Silva RB, Mourao-Sa DS, Fernandez PL, Sassaki GL, Mulloy B, Bozza MT, Barreto-Bergtor E. 2006. An α-glucan of Pseudallescheria boydii is involved in fungal phagocytosis and Toll-like receptor activation. J Biol Chem. 281:22614-22623.
7. Blows JM, Calder PC, Geddes R, Wills PR. 1988. The structure of placental glycogen. Placenta. 9:493-500.
8. Brown AM. 2004. Brain glycogen re-awakened. J Neurochem. 89:537-552. (Pubitemid 38534140)
9. Campos MA, Almeida IC, Takeuchi O, Akira S, Valente EP, Procopio DO, Travassos LR, Smith JA, Golenbock DT, Gazzinelli RT. 2001. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol. 167:416-423. (Pubitemid 32567807)
10. Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L, Ogura Y, Kawasaki A, Fukase K, Kusumoto S, et al. 2003. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopi-melic acid. Nat Immunol. 4:702-707. (Pubitemid 36874448)
11. den Dunnen J, Gringhuis SI, Geijtenbeek TB. 2009. Innate signaling by the C-type lectin DC-SIGN dictates immune responses. Cancer Immunol Immunother. 58:1149-1157.
12. Dinadayala P, Sambou T, Daffe M, Lemassu A. 2008. Comparative structural analyses of the α-glucan and glycogen from Mycobacterium bovis. Glycobiology. 18:502-508. (Pubitemid 351865830)
13. Geddes R. 1986. Glycogen: A metabolic viewpoint. Biosci Rep. 6: 415-428.
14. Geurtsen J, Chedammi S, Mesters J, Cot M, Driessen NN, Sambou T, Kakutani R, Ummels R, Maaskant J, Takata H, et al. 2009. Identification of mycobacterial oc-glucan as a novel ligand for DC-SIGN: Involvement of mycobacterial capsular polysaccharides in host immune modulation. J Immunol. 183:5221-5231.
15. Greenberg CC, Jurezak MJ, Danos AM, Brady MJ. 2006. Glycogen branches out: New perspectives on the role of glycogen metabolism in the integration of metabolic pathways. Am J Physiol Endocrinol Metab. 291: E1-E8. (Pubitemid 44035305)
16. Harada T, Miura N, Adachi Y, Nakajima M, Yadomae T, Ohno N 2002. Effect of SCG, 1,3-p-D-glucan from Sparassis crispa on the hematopoietic response in cyclophosphamide induced leukopenic mice. Biol Pharm Bull. 25:931-939. (Pubitemid 40022128)
17. Harmon CS, Phizackerley PJ. 1983. The effects of starvation and re-feeding on glycogen metabolism in mouse tail skin. Biochem J. 212:679-683. (Pubitemid 13056891)
18. Ikeda Y, Adachi Y, Ishii T, Miura N, Tamura H, Ohno N 2008. Dissociation of Toll-like receptor 2-mediated innate immune response to zymosan by organic solvent-treatment without loss of dectin-1 reactivity. Biol Pharm Bull. 31:13-18.
19. Iwasaki A, Medzhitov R. 2004. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 5:987-995. (Pubitemid 41057715)
20. Kajiura H, Kakutani R, Akiyama T, Takata H, Kuriki T. 2008. A novel enzymatic process for glycogen production. Biocatal Biotransform. 26:133-140.
21. Kajiura H, Takata H, Kuriki T, Kitamura S. 2010. Structure and solution properties of enzymatically synthesized glycogen. Carbohydr Res. 345:817-824.
22. Kakutani R, Adachi Y, Kajiura H, Takata H, Kuriki T, Ohno N. 2007. Relationship between structure and immunostimulating activity of enzymatically synthesized glycogen. Carbohydr Res. 342:2371-2379. (Pubitemid 47525518)
23. Kakutani R, Adachi Y, Kajiura H, Takata H, Kuriki T, Ohno N. 2008. Stimulation of macrophage by enzymatically synthesized glycogen: The relationship between structure and biological activity. Biocatal Biotransform. 26:152-160.
24. Lee HK, Lee J, Tobias PS. 2002. Two lipoproteins extracted from Escherichia coli K-12 LCD25 lipopolysaccharide are the major components responsible for Toll-like receptors. J Immunol. 168:4012-4017. (Pubitemid 34298406)
25. Nair PK, Melnick SJ, Ramachandran R, Escalon E, Ramachandran C. 2006. Mechanism of macrophage activation by (1,4)-oc-D-glucan isolated from Tinospora cordifolia. Int Immunopharmacol. 6:1815-1824. (Pubitemid 44557190)
26. Nair PK, Rodriguez S, Ramachandran R, Alamo A, Melnick SJ, Escalon E, Gareia PI, Jr, Wnuk SF, Ramachandran C. 2004. Immune stimulating properties of a novel polysaccharide from the medicinal plant Tinospora cordifolia. Int Immunopharmacol. 4:1645-1659. (Pubitemid 39348862)
27. O'Connell CM, AbdelRahman YM, Green E, Darville HK, Saira K, Smith B, Darville T, Scurlock AM, Meyer CR, Belland RJ. 2011. Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C trachomatis but not by C muridarum. Infect Immun. 79:1044-1056.
28. Ohno N, Egawa Y, Hashimoto T, Adachi Y, Yadomae T. 1996. Effect of (3-glucans on the nitric oxide synthesis by peritoneal macrophage in mice. Biol Pharm Bull. 19:608-612. (Pubitemid 26144620)
29. Ohno N, Uchiyama M, Tsuzuki A, Tokunaka K, Miura NN, Adachi Y, Aizawa MW, Tamura H, Tanaka S, Yadomae T. 1999. Solubilization of yeast cell-wall (3-(1-3)-D-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction. Carbohydr Res. 316:161-172. (Pubitemid 29287239)
30. Reed RC, Berwin B, Baker JP, Nicchitta CV 2003. GRP94/gp96 elicits ERK activation in murine macrophages: A role of endotoxin contamination in NFKB activation and nitric oxide production. J Biol Chem. 278:31853-31860. (Pubitemid 37048369)
31. Saijo S, Fujikado N, Furuta T, Chung SH, Kotaki H, Seki K, Sudo K, Akira S, Adachi Y, Ohno N, et al. 2007. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol. 8:39-46. (Pubitemid 46242357)
32. Salmoral EM, Tolmasky DS, Krisman CR. 1990. Evidence for the presence of glycogen in rat thymus. Cell Mol Biol. 36:163-174. (Pubitemid 20195408)
33. Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, Marsche G, Young MF, Mihalik D, Gotte M, et al. 2005. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest. 115:2223-2233. (Pubitemid 41134165)
34. Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR. 2006. Hyaluronan fragments acts as an endogenous danger signal by engaging TLR2. J Immunol. 177:1272-1281. (Pubitemid 44036633)
35. Schilling D, Thomas K, Nixdorff K, Vogel SN, Fenton MJ. 2002. Tolllike receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophage. J Immunol. 169: 5874-5880. (Pubitemid 35291692)
36. Schwandner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. 1999. Peptidoglycan-and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J Biol Chem. 274:17406-17409.
37. Scott RB, Still WJ. 1968. Glycogen in human peripheral blood leukocytes. II. The macromolecular state of leukocyte glycogen. J Clin Invest. 47:353-359.
38. Tada R, Adachi Y, Ishibashi K, Tsubaki K, Ohno N. 2008. Binding capacity of a barley β-D-glucan to the β-glucan recognition molecule dectin-1. J Agric Food Chem. 56:1442-1450. (Pubitemid 351364081)
39. Taegtmeyer H. 2004. Glycogen in the heart-an expanded view. J Mol Cell Card. 37:7-10.
40. Takaya Y, Uchisawa H, Ichinohe H, Sasaki J, Ishida K, Matsue H. 1998. Antitumor glycogen from scallops and the interrelationship of structure and antitumor activity. J Mar Biotechnol. 6:208-213. (Pubitemid 29316321)
41. Takeda K, Kaisho T, Akira S. 2003. Toll-like receptors. Annu Rev Immunol. 21:335-376. (Pubitemid 37174535)
42. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, Takeda K, Akira S. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity. 11:443-451. (Pubitemid 29504199)
43. Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA, Barnes PF, Rollinghoff M, Bolcskei PL, Wagner M, et al. 2001. Induction of direct antimicrobial activity through mammalian Toll-like receptors. Science. 291:1544-1547. (Pubitemid 32179220)
44. Toshchakov V, Jones BW, Perera PY, Thomas K, Cody MJ, Zhang S, Williams BRG, Major J, Hamilton TA, Fenton MJ, et al. 2002. TLR4, but not TLR2, mediates IFN-β-induced STAT1α/β-dependent gene expression in macrophages. Nat Immunol. 3:392-398. (Pubitemid 34308628)
45. Wallin RP, Lundqvist A, More SH, von Bonin A, Kiessling R, Ljunggren HG. 2002. Heat-shock proteins as activators of the innate immune system. Trends Immunol. 23:130-135. (Pubitemid 34178294)
46. Wang Q, McLoughlin RM, Cobb BA, Charrel-Dennis M, Zaleski KJ, Golenbock D, Tzianabos AO, Kasper DL. 2006. A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J Exp Med. 203:2853-2863. (Pubitemid 46026163)
47. Yamasaki S, Ishikawa E, Sakuma M, Hara H, Ogata K, Saito T. 2008. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat Immunol. 9:1179-1188.
48. Yoneyama M, Fujita T. 2007. Function of RIG-I-like receptors in antiviral innate immunity. J Biol Chem. 282:15315-15318. (Pubitemid 47093255)